NASDAQ:MDLN
Medline Inc.
Medline Inc.'s revenue grew 11.5% in fiscal 2025 to $28.4B while operating margin fell to 7.8%. Free cash flow was $1.3B, 4.6% of revenue.Summary generated from Medline Inc.'s SEC filings. Latest annual report filed Feb 25, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$28.4B
Revenue growth+11.5%
Revenue, 5-yr CAGRn/a
Gross margin26.4%
Operating margin7.8%
Net margin4.1%
ROICn/a
Return on equityn/a
Debt / equity1.17
Free cash flow$1.3B
FCF margin4.6%
Share count changen/a
Financials
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 23.2 | 25.5 | 28.4 |
| Operating income | 1.3 | 2.1 | 2.2 |
| Net income | 0.2 | 1.2 | 1.2 |
| Free cash flow | 1.4 | 1.4 | 1.3 |
Recent filings
- 4Insider transaction report
Oct 6, 2026 - 4Insider transaction report
Aug 21, 2026 - 10-QQuarterly report for the period ended Jun 27, 2026
Aug 5, 2026 - 8-KResults of operations and financial condition
Aug 5, 2026 - 8-KDirector or officer change
Jul 9, 2026 - 8-KResults of a shareholder vote
Jun 12, 2026 - 8-KEntry into a material agreement
Jun 2, 2026 - S-1Registration statement
May 20, 2026